Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Gastroenterology · Crohn's Anal Fistula

Does Stem Cell Therapy Work for Crohn's Anal Fistulas?

At a Glance

Mesenchymal stem cell therapy is a minimally invasive treatment that injects healthy donor cells into a Crohn's anal fistula to reduce inflammation and heal tissue. It is a sphincter-sparing option that avoids incontinence risks, though it is currently only available in the US via clinical trials.

Stem cell therapy is an innovative, minimally invasive treatment for complex anal fistulas in people with Crohn’s disease whose fistulas have not healed with standard biologics or conventional surgery [1][2]. The treatment uses mesenchymal stem cells (often a specific therapy called darvadstrocel, or Alofisel), which are specialized cells derived from healthy donor fat tissue [2]. Instead of physically cutting out or opening the fistula tract, doctors inject these stem cells directly into the walls of the fistula to calm the local immune response and help the tissue heal from the inside out [3][4].

Note on Availability: While darvadstrocel is approved for use in Europe, the UK, and Japan, it is not currently FDA-approved in the United States. In the US, it may only be accessible through clinical trials.

How Does the Treatment Work?

The procedure is typically performed in an operating room while you are under anesthesia. The therapy relies on two major steps: careful surgical preparation and the stem cell injection itself [2][5].

The Procedure

First, the surgeon cleans out the fistula tract (a process called curettage) and mechanically closes the internal opening inside the rectum [2][5]. If you currently have setons in place to keep the fistula draining, they are removed during this surgical preparation. After the tract is prepared, the surgeon injects a solution containing millions of stem cells directly into the tissue walls surrounding the fistula [2].

The Mechanism of Healing

Unlike medications that you take as a pill or infusion, these stem cells act locally at the site of the fistula. They promote healing through two main mechanisms:

  • Calming Inflammation (Immunomodulation): Crohn’s fistulas are kept open by constant, localized inflammation. The injected stem cells interact with your immune cells and release signals that dial down this overactive immune response, creating an environment where healing can begin [3][4].
  • Tissue Regeneration: Once the inflammation is reduced, the stem cells encourage the growth of new blood vessels and support the natural regeneration of healthy tissue, encouraging the fistula tract to fill in and close [3][4].
  • No Match Required: Even though the cells come from a donor, mesenchymal stem cells do not require a genetic match. They do not trigger a rejection response in your body, meaning you do not need to take anti-rejection drugs like an organ transplant patient would [2].

How Effective Is It?

Research shows that stem cell therapy can offer significant hope for stubborn fistulas. In a landmark clinical trial called ADMIRE-CD, 50% of patients who received the stem cell injection achieved combined remission—meaning the external openings closed and an MRI confirmed there were no hidden abscesses—compared to 34% in the placebo group [2]. Long-term follow-up has shown that this healing can be sustained for up to two years or more [6][7].

However, a more recent phase 3 trial (ADMIRE-CD II) failed to meet its primary goal. It showed that the stem cell injection did not outperform the placebo. In this study, nearly half of the patients in both the stem cell group and the placebo group achieved remission [5]. This finding underscores that the meticulous surgical cleaning and closure of the internal opening (which both groups received) is a powerful driver of healing on its own, though the stem cell injection remains a valuable tool for complex, hard-to-treat cases [5].

Safety and Patient Eligibility

One of the biggest advantages of stem cell therapy is its favorable safety profile [1][8]. Because the treatment involves injections rather than cutting through the anal sphincter muscles, it does not increase the risk of fecal incontinence—a common concern with traditional fistula surgeries [9][10].

The therapy is generally well-tolerated, with the most common side effects being typical postoperative issues like temporary pain or the development of an anal abscess [2][11].

It is specifically indicated for adults whose intestinal (luminal) Crohn’s disease is either inactive or only mildly active [12]. If your intestinal inflammation is severe, your medical team will likely focus on calming the gut before attempting stem cell therapy for a fistula [12]. You will generally continue taking your standard Crohn’s medications (like biologics) to keep your intestinal disease controlled while the fistula heals.

What to Expect During Recovery

Following the procedure, you may experience some mild discomfort or pain in the perianal area, similar to other minor anal surgeries. While recovery is generally faster than with traditional sphincter-cutting surgeries, you will still need to limit strenuous activities for a short period to allow the internal closure to heal. Your doctor will likely schedule a follow-up exam and an MRI—usually several months later (e.g., at 6 months)—to confirm whether the fistula has truly healed internally.

Common questions in this guide

How do stem cells heal a Crohn's anal fistula?
Stem cells are injected directly into the fistula walls during a surgical procedure. Once there, they help calm local inflammation and encourage the growth of new blood vessels, allowing the fistula tract to heal and close from the inside out.
Is stem cell therapy for anal fistulas available in the US?
Currently, darvadstrocel (the specific stem cell therapy used for this procedure) is not FDA-approved in the United States and is typically only accessible through clinical trials. However, it is an approved treatment in Europe, the United Kingdom, and Japan.
Will I need to take anti-rejection drugs after a stem cell injection?
No, you will not need anti-rejection medications. The mesenchymal stem cells used in this treatment do not require a genetic match and do not trigger a rejection response from your body's immune system.
Does stem cell therapy for fistulas increase the risk of bowel incontinence?
Because the procedure involves injecting cells rather than physically cutting through the anal sphincter muscles, it does not increase your risk of developing fecal incontinence. This makes it a favorable alternative to traditional sphincter-cutting surgeries.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is darvadstrocel (Alofisel) currently available in my country, or would I need to enroll in a clinical trial to access it?
  2. 2.Given my specific fistula anatomy and my current Crohn's disease activity, am I a good candidate for this procedure?
  3. 3.What is your preferred surgical preparation (such as curettage and closing the internal opening), and how does that influence the success rate?
  4. 4.How should we manage my current setons and biologic medications leading up to and following the procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta-analysis.

    Taxonera C, García-Brenes MA, Olivares D, et al.

    United European gastroenterology journal 2025; (13(3)):416-426 doi:10.1002/ueg2.12673.

    PMID: 39360706
  2. 2

    Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

    Panés J, García-Olmo D, Van Assche G, et al.

    Lancet (London, England) 2016; (388(10051)):1281-90.

    PMID: 27477896
  3. 3

    Needles for healing: stem cells, platelet-enriched plasma, and fat injection in perianal fistulizing Crohn's disease.

    Takata E, Lee JJ, Lightner AL

    Techniques in coloproctology 2026; (30(1)).

    PMID: 42128989
  4. 4

    A Comprehensive Exploration of Therapeutic Strategies in Inflammatory Bowel Diseases: Insights from Human and Animal Studies.

    Dias IE, Dias IR, Franchi-Mendes T, et al.

    Biomedicines 2024; (12(4)) doi:10.3390/biomedicines12040735.

    PMID: 38672091
  5. 5

    Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.

    Colombel JF, Garcia Olmo D, Chen ST, et al.

    Gastroenterology 2026; (170(7)):1562-1570 doi:10.1053/j.gastro.2025.12.033.

    PMID: 41790076
  6. 6

    INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial.

    Panés J, Bouma G, Ferrante M, et al.

    Inflammatory bowel diseases 2022; (28(11)):1737-1745 doi:10.1093/ibd/izab361.

    PMID: 35099555
  7. 7

    Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.

    Garcia-Olmo D, Gilaberte I, Binek M, et al.

    Diseases of the colon and rectum 2022; (65(5)):713-720 doi:10.1097/DCR.0000000000002325.

    PMID: 34890373
  8. 8

    Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study).

    Herreros MD, Ramirez JM, Otero-Piñeiro AM, et al.

    Diseases of the colon and rectum 2024; (67(7)):960-967 doi:10.1097/DCR.0000000000003216.

    PMID: 38603800
  9. 9

    Management and Treatment of Perianal Fistulizing Crohn's Disease.

    Lee JJ, Lightner AL

    Clinical and experimental gastroenterology 2025; (18()):291-303 doi:10.2147/CEG.S528149.

    PMID: 41415490
  10. 10

    Managing Complex Perianal Fistulizing Disease.

    Pedersen KE, Lightner AL

    Journal of laparoendoscopic & advanced surgical techniques. Part A 2021; (31(8)):890-897 doi:10.1089/lap.2021.0285.

    PMID: 34314631
  11. 11

    A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions.

    Lightner AL, Wang Z, Zubair AC, Dozois EJ

    Diseases of the colon and rectum 2018; (61(5)):629-640 doi:10.1097/DCR.0000000000001093.

    PMID: 29578916
  12. 12

    Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease-A prospective nationwide multicenter cohort study.

    Dawoud C, Widmann KM, Czipin S, et al.

    Wiener klinische Wochenschrift 2024; (136(9-10)):289-294 doi:10.1007/s00508-023-02283-4.

    PMID: 37823920

This page explains stem cell therapy for Crohn's anal fistulas for educational purposes only. Always consult your gastroenterologist or colorectal surgeon to discuss whether you are a candidate for this procedure.

Get notified when new evidence is published on Anal fistula.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.